Wilson Sonsini Goodrich & Rosati represented Ochre Bio in the transaction. Ochre Bio, a pioneer in chronic liver disease medicine development, announced the start of a...
Ochre Bio’s $37.5 Million License Agreement with GSK
Cornerstone’s Acquisition of SkyHive
Wilson Sonsini Goodrich & Rosati represented SkyHive Technologies Holdings in the transaction, and Sidley Austin represented Cornerstone OnDemand, Inc.. Cornerstone OnDemand Inc., a leader in Workforce...
Matter Brands’ Acquisition of CLCKR Product Line from STRAX
Wilson Sonsini Goodrich & Rosati advised Matter Brands on the transaction. Gadget Guard, a wireless phone accessory company, announced the launch of its new parent company,...
Aledade’s Acquisition of Medical Advantage
Wilson Sonsini Goodrich & Rosati advised Aledade on the transaction. Aledade, the nation’s largest and most successful network of physician-led value-based care, announced that it has...
Armis’ $150 Million Acquisition of Silk Security
Sidley Austin advised Armis on the transaction, and Wilson Sonsini Goodrich & Rosati advised Silk Security. Armis, the asset intelligence cybersecurity company, announced that it has...
IBM’s $6.4 Million Acquisition of HashiCorp
Paul Weiss Rifkind Wharton & Garrison is advising IBM on the transaction, and Wilson Sonsini Goodrich & Rosati is advising HashiCorp. IBM (NYSE: IBM) and HashiCorp Inc....
Montrose Environmental’s $128 Million Follow-On Offering
Gibson, Dunn & Crutcher advised Montrose Environmental Group, Inc. on the offering, and Wilson Sonsini Goodrich & Rosati advised the underwriters. Montrose Environmental Group, Inc. (NYSE:...
UpLift’s Acquisition of TAO Connect
Wilson Sonsini Goodrich & Rosati represented UpLift in the transaction. UpLift, a technology-driven behavioral health company delivering in-network therapy and psychiatry, announced that it has acquired...
Linden Capital Partners’ Acquisition of Alcresta Therapeutics
Kirkland & Ellis represented Linden Capital Partners, Wilmer Cutler Pickering Hale and Dorr represented Alcresta Therapeutics and Wilson Sonsini Goodrich & Rosati advised HealthQuest Capital. Linden...
Rambus’ $50 Million Accelerated Share Repurchase Program
Wilson Sonsini Goodrich & Rosati represented Rambus in the transaction. Rambus Inc. (NASDAQ: RMBS) announced that it initiated an accelerated share repurchase program with Royal Bank of Canada...
Webull’s Business Combination with SK Growth
Kirkland & Ellis is representing WeBull Corporation in the transaction, and Wilson Sonsini Goodrich & Rosati is representing SK Growth Opportunities Corporation. Webull Corporation (“Webull” or the...
Entrust’s Acquisition of Onfido
Latham & Watkins represented Entrust in the transaction, and Wilson Sonsini Goodrich & Rosati represented Onfido. Entrust, a global leader in trusted payments, identities, and data...